Sildenafil Tablet, Film Coated
Product Images NDC 72241-070

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 72241-070). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Modavar Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig-1 (Fig 1)

A line graph comparing the effects of Sildenafil 100 mg versus placebo on systolic blood pressure over 24 hours post-dose. The x-axis represents time in hours, while the y-axis shows changes in systolic blood pressure (mmHg). Data points are plotted for pre-dose and multiple time intervals up to 24 hours, showing fluctuations for both Sildenafil and placebo groups.*

FDA Label Image

Fig-2 (Fig 2)

A line graph showing the change in systolic blood pressure (SBP) in mmHG over time postdose in hours for two treatments: Doxazosin with Placebo and Doxazosin with Sildenafil 25 mg. The y-axis measures change in SBP, and the x-axis shows time from 0 to 8 hours. The graph illustrates that the combination with Sildenafil 25 mg generally results in a greater reduction in SBP compared to the combination with Placebo throughout the 8-hour period.*

FDA Label Image

Fig-3 (Fig 3)

A line graph showing the change in systolic blood pressure (SBP) in mmHg over an 8-hour period postdose. It compares two treatments: Doxazosin with placebo and Doxazosin with Sildenafil 50 mg. Data points are plotted hourly, indicating fluctuations in SBP change for each treatment group.*

FDA Label Image

Fig-4 (Fig 4)

A line graph showing the change in blood pressure (mmHg) over time (hours) after dosing with Doxazosin combined with Sildenafil 100 mg versus Doxazosin combined with placebo. The graph illustrates the blood pressure variations from 0 to 8 hours post-dose, comparing the effects of the two treatments.*

FDA Label Image

Fig-5 (Fig 5)

A line graph showing plasma concentrations (ng/ml) of a commercial sildenafil tablet over time post dose (hours). The graph starts near zero concentration, peaks sharply around 1 hour, then gradually decreases to near baseline by 24 hours, illustrating the drug's plasma concentration profile after oral administration.*

FDA Label Image

Fig-6-1 (Fig 6 1)

A bar chart showing the percentage of patients at endpoint based on baseline scores ranging from 0 to 5. Each baseline score has a set of vertical bars representing different categories labeled 0 to 5, with the height of bars indicating varying patient percentages. The chart appears to visualize patient outcome distributions.*

FDA Label Image

Fig-6-2 (Fig 6 2)

A bar chart titled 'Effect of Placebo on Maintenance of Erection by Baseline Score,' illustrating the percentage of patients at endpoint across baseline scores from 0 to 5. Multiple bars per baseline score represent different categories labeled 0 through 5, with varying heights showing patient distribution percentages by category at each score.*

FDA Label Image

Fig-7 (Fig 7)

A vertical bar chart showing the percentage of patients reporting improvement for sildenafil citrate tablets at three strengths (25 mg, 50 mg, and 100 mg) compared to placebo. The chart indicates increasing improvement percentages from placebo (24%) to sildenafil 25 mg (63%), 50 mg (74%), and 100 mg (82%).*

FDA Label Image

Modavar-cont-label-1000mg-100-tab.jpg (Modavar Cont Label 1000mg 100 Tab)

Label for Sildenafil Tablets, USP 100 mg film-coated oral tablets by Modavar Pharmaceuticals LLC. The label indicates prescription use, package size of 1000 tablets, and storage instructions. It includes manufacturer details for Cadila Pharmaceuticals Ltd., India, and Modavar Pharmaceuticals LLC, Washington, DC. The label also contains a barcode and a note for serialized data matrix code and batch coding area.*

FDA Label Image

Modavar-cont-label-100mg-100-tab.jpg (Modavar Cont Label 100mg 100 Tab)

Sildenafil Tablets, USP 100 mg film-coated tablets packaging label from Modavar Pharmaceuticals LLC. The label includes storage instructions, manufacturer and distributor information, and a barcode. The package contains 100 tablets with Rx only designation.*

FDA Label Image

Modavar-cont-label-100mg-30-tab.jpg (Modavar Cont Label 100mg 30 Tab)

Label for Sildenafil Tablets USP 100 mg by Modavar Pharmaceuticals LLC showing a 30-tablet package. The film-coated oral tablets are manufactured by Cadila Pharmaceuticals Ltd., with storage instructions and safety warnings. The label includes dosage strength, NDC number 72241-071-22, and barcode information.*

FDA Label Image

Modavar-cont-label-25mg-100-tab.jpg (Modavar Cont Label 25mg 100 Tab)

Sildenafil Tablets USP 25 mg film-coated tablets label showing Modavar Pharmaceuticals as labeler. The label indicates 100 tablets per container with storage instructions and barcode. Manufactured by Cadila Pharmaceuticals Ltd. in India for Modavar Pharmaceuticals LLC, Washington DC. Includes dosage form and strength details.*

FDA Label Image

Modavar-cont-label-25mg-1000-tab.jpg (Modavar Cont Label 25mg 1000 Tab)

Sildenafil tablets, USP 25 mg film-coated tablets bottle label from Modavar Pharmaceuticals LLC. The label states the NDC 72241-069-11 and indicates the package contains 1000 tablets. It includes storage instructions, manufacturer details including Cadila Pharmaceuticals Ltd. in India, and a barcode. The label notes the product is prescription only.*

FDA Label Image

Modavar-cont-label-25mg-30-tab.jpg (Modavar Cont Label 25mg 30 Tab)

Sildenafil Tablets USP 25 mg film-coated tablets package label by Modavar Pharmaceuticals LLC. The label shows the product strength 25 mg, quantity of 30 tablets, and includes storage instructions. It states the manufacturer as Cadila Pharmaceuticals Ltd in India and Modavar Pharmaceuticals LLC in Washington, DC. The label includes an NDC number 72241-069-22 and a barcode.*

FDA Label Image

Modavar-cont-label-50mg-100-tab.jpg (Modavar Cont Label 50mg 100 Tab)

Sildenafil Tablets, USP 50 mg film-coated oral tablets by Modavar Pharmaceuticals LLC. The label indicates 100 tablets per bottle with NDC 72241-070-05. Manufactured by Cadila Pharmaceuticals Ltd., India, and labeled for Modavar Pharmaceuticals LLC, Washington, DC. Includes storage instructions and barcode on the side.*

FDA Label Image

Modavar-cont-label-50mg-1000-tab.jpg (Modavar Cont Label 50mg 1000 Tab)

Label for Sildenafil Tablets, USP 50 mg by Modavar Pharmaceuticals LLC. It shows the product name, strength 50 mg, and dosage form as film-coated tablets. The label includes storage instructions, dosage usage directions, manufacturer details (Cadila Pharmaceuticals Ltd. and Modavar Pharmaceuticals LLC), tablet count of 1000, and a barcode. Additional text mentions that each tablet contains sildenafil citrate equivalent to 50 mg sildenafil.*

FDA Label Image

Modavar-cont-label-50mg-30-tab.jpg (Modavar Cont Label 50mg 30 Tab)

Packaging label for Sildenafil Tablets, USP 50 mg film-coated tablets by Modavar Pharmaceuticals LLC. The label includes the NDC 72241-070-22, indicates prescription use only, and states that the package contains 30 tablets. It also lists manufacturing details including Cadila Pharmaceuticals Ltd. in Gujarat, India, and Modavar Pharmaceuticals LLC in Washington, DC. The label includes storage instructions and a barcode.*

FDA Label Image

Structure (Structure)

Chemical structure of Sildenafil displayed in a black and white line diagram showing molecular components and connectivity.*

FDA Label Image

Hemodynamic (Table 3)

A data table presenting cardiovascular measurements at rest and after 4 minutes of exercise. It compares baseline values and values after Sildenafil administration for parameters including PAOP, Mean PAP, Mean RAP, Systolic SAP, Diastolic SAP, Cardiac output, and Heart rate, with sample sizes and standard deviations.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.